Electrodes

Two different electrode worlds under one label: graphite electrodes- ultra-high-power consumables for electric-arc-furnace steelmaking, made by a listed Indian duopoly exporting ~65-70% of output- and welding electrodes/consumables for fabrication, plus specialty electrochemical electrodes; graphite electrodes dominate the cohort's value

Grade and reliability differentiation: UHP electrodes qualifying into demanding EAF operations, decades of process know-how, and cost positions (the Indian leaders run 90%+ utilisation against a global average of 60-65%) let them survive troughs that break competitors

Specialty niches add a further layer: electrochemical electrodes for chlor-alkali and related processes reward application engineering distinct from graphite or welding consumables, though this remains a small slice of cohort value

Within-grade commoditisation: within a grade, the product is a globally traded commodity- Chinese capacity overhangs pricing, and differentiation shows up in who survives cycles, not in premium pricing

Customers are global EAF steelmakers buying on annual/spot contracts- concentrated, price-sensitive, and served by a handful of qualified suppliers worldwide; welding-consumable customers (fabricators, infrastructure projects) are fragmented and steadier

Customer base structurally expanding: decarbonisation is driving an EAF build-out described by industry leaders as unprecedented (~110 million tonnes of new capacity, implying ~150-200 thousand tonnes of incremental electrode demand by 2030 against a ~650 thousand tonne ex-China market)

Pricing power is cyclical and collective: the recent trough forced losses industry-wide until the global price leader announced steep increases (2026), and Indian realisations follow global moves they cannot initiate alone

Needle coke- the critical petroleum-derived input- dominates cost and is imported, with battery-anode makers now competing for the same supply; power and rupee-denominated fixed costs fill the rest, making margins a violent function of the electrode-price-minus-needle-coke spread

The cycle is the cost structure's story: the same companies swing from record profits (the 2018 supercycle, the current recovery with quarterly profits at multi-year highs) to outright losses at the trough, with low-cost positions and debt-free balance sheets deciding who endures

Operating leverage cuts favourably in upcycles: rupee costs against dollar-linked revenue mean each price increase drops disproportionately to profit, and the leaders' utilisation discipline through the trough positions them for the recovery

Diversification capex is the new cost frontier: graphite-anode plants for lithium-ion batteries (a ~Rs 1,850 crore 20,000-tonne facility commissioning 2027 at one player, with corporate demergers separating the clean-tech build-outs) invest today's electrode cash into tomorrow's battery materials

The structural demand driver is steel decarbonisation- every blast-furnace-to-EAF conversion worldwide adds electrode demand, and the 5-7 year outlook combines that build-out with India's own EAF/scrap-route growth

Battery-materials pivot is the second engine: synthetic graphite anodes for lithium-ion cells (projected Indian demand of ~1.4 lakh tonnes by 2030) let electrode makers redeploy graphitisation expertise into a structurally growing adjacency with attractive guided returns

Cycle timing turning favourable: global price increases, capacity rationalisation among weaker producers and two years of underinvestment set up the recovery the industry has waited for

Welding consumables provide a steadier base: riding infrastructure and fabrication spend with far less volatility than the graphite-electrode cycle, a useful counterweight within the same listed entities

Caveats: China sits outside every favourable calculation (its exports cap prices), EAF conversion timelines slip with steel economics, and the anode ventures are execution stories not yet earning

A genuine global oligopoly in graphite electrodes- two listed Indian producers (one the world's largest single-site plant) among a handful of ex-China suppliers, competing with American, Japanese and European peers- while welding consumables are fragmented among branded players and imports

Real entry barriers: graphitisation technology, needle-coke sourcing relationships, customer qualification and the capital/patience to survive multi-year troughs have kept the ex-China supplier set essentially closed for decades

China is the permanent asymmetry: its capacity additions serve its own market but its exports discipline everyone's pricing, and in the new anode adjacency Chinese incumbents hold overwhelming technology and scale leads

Extreme cyclicality is the defining risk in this cohort- earnings swing from records to losses within two years on electrode-needle-coke spreads, making leverage fatal and timing everything

Raw-material security tightening: needle coke faces competing battery demand and geopolitical supply concentration, threatening margins even in strong electrode markets

Customer concentration adds risk: a handful of global EAF steelmakers and trading houses account for a large share of graphite-electrode volumes, so any one buyer's capacity decisions or contract renegotiation can swing utilisation

Anode diversification carries venture risk: technology qualification, customer wins and cost competitiveness against Chinese incumbents are all unproven at scale

Offsetting: the decarbonisation-driven EAF transition gives graphite electrodes their first structural (not merely cyclical) demand story in decades, and the Indian duopoly enters it debt-light, low-cost and with utilisation leadership